CRISPR Therapeutics AG ($CRSP)
KASINGER JAMES R. โ General Counsel and Secretary
Shares
18,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Nov 2, 2026
EPS:-1.15 (est: -1.04)+10.6%
Revenue:$12.67M (est: $14.75M)-14.1%
Nov 9, 2026
EPS:Est: -1.04
Revenue:Est: $14.75M
Transaction Details
| Insider | KASINGER JAMES R. |
|---|---|
| Title | General Counsel and Secretary |
| Transaction Date | Oct 26, 2026 |
| Expiration Date | Oct 26, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Oct 28, 2026 |
| Shares Purchased | 18,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 18,000 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-436443 |
| Document | View SEC Filing |